Anti-EPHB6/ HEP monoclonal antibody

Anti-EPHB6/ HEP antibody for FACS & in-vivo assay

Target products collectionGo to EPHB6/EPHB6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T72732-Ab-1/ GM-Tg-hg-T72732-Ab-2Anti-Human EPHB6 monoclonal antibodyHuman
GM-Tg-rg-T72732-Ab-1/ GM-Tg-rg-T72732-Ab-2Anti-Rat EPHB6 monoclonal antibodyRat
GM-Tg-mg-T72732-Ab-1/ GM-Tg-mg-T72732-Ab-2Anti-Mouse EPHB6 monoclonal antibodyMouse
GM-Tg-cynog-T72732-Ab-1/ GM-Tg-cynog-T72732-Ab-2Anti-Cynomolgus/ Rhesus macaque EPHB6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T72732-Ab-1/ GM-Tg-felg-T72732-Ab-2Anti-Feline EPHB6 monoclonal antibodyFeline
GM-Tg-cang-T72732-Ab-1/ GM-Tg-cang-T72732-Ab-2Anti-Canine EPHB6 monoclonal antibodyCanine
GM-Tg-bovg-T72732-Ab-1/ GM-Tg-bovg-T72732-Ab-2Anti-Bovine EPHB6 monoclonal antibodyBovine
GM-Tg-equg-T72732-Ab-1/ GM-Tg-equg-T72732-Ab-2Anti-Equine EPHB6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T72732-Ab-1/ GM-Tg-hg-T72732-Ab-2; GM-Tg-rg-T72732-Ab-1/ GM-Tg-rg-T72732-Ab-2;
GM-Tg-mg-T72732-Ab-1/ GM-Tg-mg-T72732-Ab-2; GM-Tg-cynog-T72732-Ab-1/ GM-Tg-cynog-T72732-Ab-2;
GM-Tg-felg-T72732-Ab-1/ GM-Tg-felg-T72732-Ab-2; GM-Tg-cang-T72732-Ab-1/ GM-Tg-cang-T72732-Ab-2;
GM-Tg-bovg-T72732-Ab-1/ GM-Tg-bovg-T72732-Ab-2; GM-Tg-equg-T72732-Ab-1/ GM-Tg-equg-T72732-Ab-2
Products NameAnti-EPHB6 monoclonal antibody
Formatmab
Target NameEPHB6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EPHB6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species EPHB6/ HEP VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000240human EvGM6 Lentivirus particle
    ORF Viral VectorpGMLV000240human EpGM6 Lentivirus plasmid


    Target information

    Target IDGM-T72732
    Target NameEPHB6
    Gene ID2051,13848,312275,704886,119874627,101085965,529800,100055465
    Gene Symbol and SynonymsCekl,EPHB6,HEP,Mep
    Uniprot AccessionO15197,P0C0K7
    Uniprot Entry NameEPHB6_HUMAN,EPHB6_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000106123
    Target ClassificationKinase

    The target: EPHB6, gene name: EPHB6, also named as HEP. This gene encodes a member of a family of transmembrane proteins that function as receptors for ephrin-B family proteins. Unlike other members of this family, the encoded protein does not contain a functional kinase domain. Activity of this protein can influence cell adhesion and migration. Expression of this gene is downregulated during tumor progression, suggesting that the protein may suppress tumor invasion and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.